Pharmacogenomic response of low dose haloperidol in critically ill adults with delirium

van den Boogaard, 2018, Effect of haloperidol on survival among critically ill adults with a high risk of delirium: the REDUCE randomized clinical trial, JAMA., 319, 680, 10.1001/jama.2018.0160 Al-Qadheeb, 2016, Preventing ICU subsyndromal delirium conversion to delirium with low-dose IV haloperidol: a double-blind, placebo-controlled pilot study, Crit Care Med, 44, 583, 10.1097/CCM.0000000000001411 Girard, 2010, Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial, Crit Care Med, 38, 428, 10.1097/CCM.0b013e3181c58715 Page, 2013, Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial, Lancet Respir Med, 1, 515, 10.1016/S2213-2600(13)70166-8 Khan, 2018, Preventing postoperative delirium after major noncardiac thoracic surgery-a randomized clinical trial, J Am Geriatr Soc, 66, 2289, 10.1111/jgs.15640 van Schijndel, 2018, Haloperidol serum concentrations in critically ill patients included in the REDUCE study, Intensive Care Med, 44, 1774, 10.1007/s00134-018-5348-9 Sychev, 2017, Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration, Drug Metab Pers Ther, 32, 129 Wijnen, 2007, Review article: the prevalence and clinical relevance of cytochrome P450 polymorphisms, Aliment Pharmacol Ther, 26, 211, 10.1111/j.1365-2036.2007.03490.x Spriet, 2009, Mini-series: II. Clinical aspects. Clinically relevant CYP450-mediated drug interactions in the ICU, Intensive Care Med, 35, 603, 10.1007/s00134-008-1383-2 Ulrich, 1998, The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia, Clin Pharmacokinet, 34, 227, 10.2165/00003088-199834030-00005 Devlin, 2018, Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU, Crit Care Med, 46, e825, 10.1097/CCM.0000000000003299 Bergeron, 2001, Intensive care delirium screening checklist: evaluation of a new screening tool, Intensive Care Med, 27, 859, 10.1007/s001340100909 D.A. Flockart, Flockart, Clinical pharmacology/drug interactions/flockert table TM, Indiana University, Available from: http://medicine.iupui.edu/clinpharm/ddis/main-table/. Kennisbank Ista, 2014, Improvement of care for ICU patients with delirium by early screening and treatment: study protocol of iDECePTIvE study, Implement Sci, 9, 143, 10.1186/s13012-014-0143-7 Trogrlic, 2019, Improved guideline adherence and reduced brain dysfunction after a multicenter multifaceted implementation of ICU delirium guidelines in 3,930 patients, Crit Care Med, 47, 419, 10.1097/CCM.0000000000003596 Administration Girard, 2018, Haloperidol and ziprasidone for treatment of delirium in critical illness, N Engl J Med, 379, 2506, 10.1056/NEJMoa1808217 Slooff, 2018, Monitoring haloperidol plasma concentration and associated adverse events in critically ill children with delirium: first results of a clinical protocol aimed to monitor efficacy and safety, Pediatr Crit Care Med, 19, e112, 10.1097/PCC.0000000000001414